These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1267763)

  • 41. Proceedings: The neurohypophysial content of vasopressin, oxytocin and neurophysins A, B and C in rats injected with vasopressin tannate.
    Bakker HR; Dyball RE; Jones CW
    J Endocrinol; 1975 Jun; 65(3):60P. PubMed ID: 1151259
    [No Abstract]   [Full Text] [Related]  

  • 42. Deuteron magnetic resonance studies on the microdynamical behavior of partially deuterated oxytocin with neurophysin.
    Glasel JA; Hruby VJ; McKelvy JF; Spatola AF
    J Mol Biol; 1973 Sep; 79(3):555-75. PubMed ID: 4758065
    [No Abstract]   [Full Text] [Related]  

  • 43. Propressophysin in human blood: a possible marker of ectopic vasopressin production.
    Yamaji T; Ishibashi M; Hori T
    J Clin Endocrinol Metab; 1984 Sep; 59(3):505-12. PubMed ID: 6086701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nature of the immunoreactive neurophysins in ectopic vasopressin-producing oat cell carcinomas of the lung. Demonstration of a putative common precursor to vasopressin and neurophysin.
    Yamaji T; Ishibashi M; Katayama S
    J Clin Invest; 1981 Aug; 68(2):388-98. PubMed ID: 6267103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A rapid, efficient synthesis of oxytocin and 8-arginine-vasopressin. Comparison of benzyl, p-methoxybenzyl, and p-methylbenzyl as protecting groups for cysteine.
    Live DH; Agosta WC; Cowburn D
    J Org Chem; 1977 Oct; 42(22):3556-61. PubMed ID: 915577
    [No Abstract]   [Full Text] [Related]  

  • 46. [Neurophysins and small-cell pulmonary cancer].
    Pirard F; Pequeux C; Hendrick JC; Legros JJ
    Rev Med Liege; 1997; 52(1):22-6. PubMed ID: 9064712
    [No Abstract]   [Full Text] [Related]  

  • 47. The tyrosine ring of oxytocin undergoes hindered rotation when the hormone is bound to neurophysin.
    Blumenstein M; Hruby VJ; Viswanatha V
    Biochem Biophys Res Commun; 1980 May; 94(2):431-7. PubMed ID: 7396908
    [No Abstract]   [Full Text] [Related]  

  • 48. Oxytocin and vasopressin: photoaffinity labeling of neurophysins, secretory granule hormone-binding proteins.
    Abercrombie DM; Chaiken IM
    Pharmacol Ther; 1987; 33(2-3):209-19. PubMed ID: 3310032
    [No Abstract]   [Full Text] [Related]  

  • 49. Crystallization of complexes of neurophysins with vasopressin and oxytocin.
    Hope DB; Hollenberg MD
    Proc R Soc Lond B Biol Sci; 1968 May; 170(1018):37-47. PubMed ID: 4384881
    [No Abstract]   [Full Text] [Related]  

  • 50. Proceedings: Physiological studies of arginine-vasopressin by radioimmunoassay with two immunologically distinct antisera.
    Thomas TH; Lee MR
    J Endocrinol; 1976 Jun; 69(3):5P. PubMed ID: 950544
    [No Abstract]   [Full Text] [Related]  

  • 51. Binding properties of bovine neurophysins I and II: an equilibrium dialysis study.
    Breslow E; Walter R
    Mol Pharmacol; 1972 Jan; 8(1):75-81. PubMed ID: 5061519
    [No Abstract]   [Full Text] [Related]  

  • 52. The pituitary hormones arginine vasopressin-neurophysin II and oxytocin-neurophysin I show close linkage with interleukin-1 on mouse chromosome 2.
    Marini JC; Nelson KK; Battey J; Siracusa LD
    Genomics; 1993 Jan; 15(1):200-2. PubMed ID: 8432536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular considerations in the interaction of arginine vasopressin with a specific antiserum.
    Burford G; Lutterodt A; Moore G; Lederis K
    Proc West Pharmacol Soc; 1977; 20():521-5. PubMed ID: 896861
    [No Abstract]   [Full Text] [Related]  

  • 54. Characterization of oxytocin, vasopressin, and neurophysin from the bovine corpus luteum.
    Wathes DC; Swann RW; Birkett SD; Porter DG; Pickering BT
    Endocrinology; 1983 Aug; 113(2):693-8. PubMed ID: 6872945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurophysins: molecular and cellular aspects.
    Acher R
    Angew Chem Int Ed Engl; 1979 Nov; 18(11):846-60. PubMed ID: 118684
    [No Abstract]   [Full Text] [Related]  

  • 56. Conformational studies on synthetic peptides reproducing the dibasic processing site of pro-ocytocin-neurophysin.
    Di Bello C; Simonetti M; Dettin M; Paolillo L; D'Aurla G; Falcigno L; Saviano M; Scatturin A; Vertuani G; Cohen P
    J Pept Sci; 1995; 1(4):251-65. PubMed ID: 9223003
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AVP- and OT-neurophysins response to apomorphine and clonidine in major depression.
    Scantamburlo G; Hansenne M; Fuchs S; Pitchot W; Pinto E; Reggers J; Ansseau M; Legros JJ
    Psychoneuroendocrinology; 2005 Oct; 30(9):839-45. PubMed ID: 15964147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Partial purification and characterization of post-proline cleaving enzyme: enzymatic inactivation of neurohypophyseal hormones by kidney preparations of various species.
    Walter R
    Biochim Biophys Acta; 1976 Jan; 422(1):138-58. PubMed ID: 2300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proton magnetic resonance study of peptide conformation: effect of trifluoroethanol on oxytocin and 8-lysine-vasopressin.
    Walter R; Glickson JD
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1199-203. PubMed ID: 4515618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Neurophysins. Molecular and cellular aspects].
    Acher R
    Biochimie; 1976; 58(8):895-911. PubMed ID: 791378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.